Diane O’Neil v. Somatics, LLC and Elektrika, Inc.

2020 DNH 208
CourtDistrict Court, D. New Hampshire
DecidedDecember 1, 2020
Docket20-cv-175-PB
StatusPublished
Cited by2 cases

This text of 2020 DNH 208 (Diane O’Neil v. Somatics, LLC and Elektrika, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diane O’Neil v. Somatics, LLC and Elektrika, Inc., 2020 DNH 208 (D.N.H. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Diane O’Neil Case No. 20-cv-175-PB v. Opinion No. 2020 DNH 208

Somatics, LLC and Elektrika, Inc.

MEMORANDUM AND ORDER

In this diversity action, Diane O’Neil, a New Hampshire

resident, has sued two out-of-state corporate defendants,

Somatics, LLC and Elektrika, Inc., stemming from injuries she

allegedly sustained as a result of electroconvulsive therapy

with the Thymatron instrument. Elektrika has moved to dismiss

the claims against it for lack of personal jurisdiction. In

response, O’Neil contends that she requires jurisdictional

discovery to show that there is specific personal jurisdiction

over Elektrika in New Hampshire. For the following reasons, I

grant O’Neil’s request for limited jurisdictional discovery and

deny without prejudice Elektrika’s motion to dismiss.

I. BACKGROUND

The Thymatron is an instrument used to treat severe

psychiatric disturbances by inducing a major motor seizure

through a brief but intense electrical current applied to a

patient’s head in a process known as electroconvulsive therapy. Compl. ¶ 6. O’Neil underwent electroconvulsive therapy with a

Thymatron at the Elliot Hospital in Manchester, New Hampshire,

from August 2016 until February 2017. Compl. ¶ 57. She

allegedly suffered brain damage and permanent neurocognitive

injuries as a result of that treatment. Compl. ¶ 2.

The complaint alleges that Elektrika is “a manufacturer and

exclusive supplier” of the Thymatron device, and that Somatics

is its “manufacturer, labeler, promoter and distributor.”

Compl. ¶¶ 6-7. The defendants are allegedly liable for, among

other things, failing to warn O’Neil about the risks of

undergoing electroconvulsive therapy and misrepresenting the

safety of the Thymatron device.

In support of its motion to dismiss, Elektrika submitted an

affidavit of its president, Jesse Pavel. See Aff. of Jesse

Pavel, Doc. No. 15-2 ¶ 3. Pavel states that Elektrika is

incorporated and headquartered in New York. Doc. No. 15-2 ¶ 5.

It has no offices, facilities, employees, agents, or other

representatives in New Hampshire. Doc. No. 15-2 ¶ 6. He

further states that Elektrika does not conduct business, sell

products, or market in New Hampshire. Doc. No. 15-2 ¶ 8.

According to Pavel, Elektrika manufactures the main body of the

Thymatron in New York and ships it to Somatics in Florida. Doc.

No. 15-2 ¶¶ 11-14. Somatics then completes the assembly,

conducts testing, and sells the finished product to healthcare

2 providers. Doc. No. 15-2 ¶¶ 15-16. Pavel states that Somatics

“is exclusively responsible for the marketing, sale, and

distribution of finished Thymatron instruments,” and that

Elektrika “does not have direct contact with purchasers or end

users of finished Thymatron instruments.” Doc. No. 15-2 ¶¶ 17,

19.

In her opposition to the motion, O’Neil has not presented

evidence establishing the existence of personal jurisdiction

over Elektrika. Instead, she contends that jurisdictional

discovery would yield such evidence. O’Neil points to

Elektrika’s exclusivity agreement with Somatics, which provides

that Elektrika is “responsible for handling any repairs of the

Thymatrons sent to be serviced.” Ex. 3 to Pl.’s Obj., Doc. No.

16-3 at 2. As a result, O’Neil anticipates that discovery will

show that Elektrika interacted with the Thymatron purchasers in

New Hampshire who requested maintenance and repair services.

O’Neil also expects to find evidence that Elektrika marketed the

Thymatron device in New Hampshire jointly with Somatics. She

bases this expectation on a 1997 contract between the two

companies, which states in its preamble that Elektrika and

Somatics have closely collaborated “in the design, manufacture,

and marketing of the Thymatron ECT device and accessories

worldwide.” Ex. B to Pl.’s Sur-reply, Doc. No. 18-3 at 2.

Finally, O’Neil points to evidence that Elektrika purchases

3 component parts for the Thymatron box from vendors located in

New York, New Jersey, and Massachusetts. See Ex. 2 to Pl.’s

Obj., Doc. No. 16-2 at 2. She contends that discovery may show

that Elektrika also utilized New Hampshire-based vendors.

II. STANDARD OF REVIEW

District courts enjoy broad discretion when deciding

whether to grant a request for jurisdictional discovery. See

United States v. Swiss Am. Bank, Ltd., 274 F.3d 610, 625-26 (1st

Cir. 2001). The request must be “timely and properly

supported,” must proffer a “colorable claim” for jurisdiction,

and must “present facts to the court which show why jurisdiction

would be found if discovery were permitted.” Id. (internal

quotation marks omitted). The plaintiff must specify the type

of evidence she expects to find and provide detailed

descriptions of any “‘additional pertinent avenues of inquiry’

that [she] hope[s] to pursue.” Id. at 626 (quoting Whittaker

Corp. v. United Aircraft Corp., 482 F.2d 1079, 1086 (1st Cir.

1973)). “Failure to allege specific contacts, relevant to

establishing personal jurisdiction, in a jurisdictional

discovery request can be fatal to that request.” Id. at 626-27

(citing Crocker v. Hilton Int’l Barbados, Ltd., 976 F.2d 797,

801 (1st Cir. 1992)).

4 III. ANALYSIS

O’Neil timely requested jurisdictional discovery as part of

her objection to Elektrika’s motion to dismiss. See Nordica USA

Corp. v. Ole Sorensen, 475 F. Supp. 2d 128, 134-35 (D.N.H. 2007)

(holding that request for jurisdictional discovery raised in

objection to Rule 12(b)(2) motion was timely). Thus, the only

question is whether she has proffered a colorable claim that

Elektrika is subject to specific jurisdiction in New Hampshire.

When assessing personal jurisdiction in a diversity case, a

federal court “is the functional equivalent of a state court

sitting in the forum state.” Baskin-Robbins Franchising LLC v.

Alpenrose Dairy, Inc., 825 F.3d 28, 34 (1st Cir. 2016) (quoting

Sawtelle v. Farrell, 70 F.3d 1381, 1387 (1st Cir. 1995)). The

court must determine whether an exercise of jurisdiction is

proper under both the forum state’s long-arm statute and the due

process requirements of the U.S. Constitution. C.W. Downer &

Co. v. Bioriginal Food & Sci. Corp., 771 F.3d 59, 65 (1st Cir.

2014). Because New Hampshire’s long-arm statute is coextensive

with the federal due process standard, however, I need only

consider whether exercising personal jurisdiction would comport

with due process. Phillips Exeter Acad. v. Howard Phillips

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
2020 DNH 208, Counsel Stack Legal Research, https://law.counselstack.com/opinion/diane-oneil-v-somatics-llc-and-elektrika-inc-nhd-2020.